Quidel Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last twelve months. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Quidel stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares.
View analyst ratings for Quidel or view top-rated stocks.

Wall Street analysts have given Quidel a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quidel wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Quidel is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Quidel.

Quidel Co. (NASDAQ:QDEL) announced its earnings results on Thursday, August, 5th. The company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $1.06 by $0.42. The company earned $176.61 million during the quarter, compared to analyst estimates of $173.29 million. Quidel had a trailing twelve-month return on equity of 73.85% and a net margin of 48.96%.
View Quidel's earnings history.

Quidel's stock was trading at $89.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, QDEL shares have increased by 64.0% and is now trading at $147.11.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued twelve-month price objectives for Quidel's shares. Their forecasts range from $80.00 to $219.00. On average, they anticipate Quidel's stock price to reach $148.50 in the next year. This suggests a possible upside of 0.9% from the stock's current price.
View analysts' price targets for Quidel or view top-rated stocks among Wall Street analysts.

47 employees have rated Quidel CEO Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among Quidel's employees.

Some companies that are related to Quidel include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), STAAR Surgical (STAA), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of QDEL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Square (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel's stock is owned by a number of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (15.75%), Vanguard Group Inc. (9.28%), BlackRock Inc. (7.90%), Brown Capital Management LLC (6.35%), State Street Corp (2.50%) and ArrowMark Colorado Holdings LLC (2.05%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll and William J Ferenczy.
View institutional ownership trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, Goldman Sachs Group Inc., AQR Capital Management LLC, BlackRock Inc., Oracle Investment Management Inc., Public Employees Retirement Association of Colorado, Assetmark Inc., and Wells Fargo & Company MN. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Mary Lake Ph D Polan, Werner Kroll, and William J Ferenczy.
View insider buying and selling activity for Quidel or view top insider-selling stocks.

QDEL stock was bought by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Senvest Management LLC, ArrowMark Colorado Holdings LLC, Price T Rowe Associates Inc. MD, Los Angeles Capital Management LLC, and Kempen Capital Management N.V.. Company insiders that have bought Quidel stock in the last two years include Douglas C Bryant, Edward L Michael, and Matthew Strobeck.
View insider buying and selling activity for Quidel or or view top insider-buying stocks.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of QDEL stock can currently be purchased for approximately $147.11.

Quidel has a market capitalization of $6.12 billion and generates $1.66 billion in revenue each year. The company earns $810.29 million in net income (profit) each year or $19.55 on an earnings per share basis.

Quidel employs 1,370 workers across the globe.

Quidel was founded in 1979.

The official website for Quidel is www.quidel.com.

Quidel is headquartered at 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at (858) 552-1100 or via email at [email protected]